Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Kitamura

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Blood|January 20, 2018
<i>ASXL1</i> mutations gain a functionToshio Kitamura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[STAT3 inhibitor]Toshio Kitamura
International Journal of Hematology|February 12, 2013
Guest editorial: Genetic and epigenetic alterations in hematopoietic malignanciesToshio Kitamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 9, 2009
[Molecular bases of leukemia, MPD and MDS]Toshio Kitamura
International Journal of Hematology|July 8, 2019
Epigenetic abnormalities and therapies for hematological malignanciesToshio Kitamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Clonal hematopoiesis]Toshio Kitamura
Experimental Hematology|July 24, 2002
Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformationTetsuya Nosaka, Toshio Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Cytogenetic abnormalities and gene mutations in myeloid leukemia]Naoko Kato, Toshio Kitamura
Experimental Hematology|July 10, 2012
HDACI-induced thrombocytopenia is caused by its unexpected targetToshio Kitamura, Daichi Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 4, 2007
[Molecular mechanisms of carcinogenesis: an outline]Toshio Kitamura, Naoke Watanabe
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Blood|January 20, 2018
<i>ASXL1</i> mutations gain a functionToshio Kitamura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[STAT3 inhibitor]Toshio Kitamura
International Journal of Hematology|February 12, 2013
Guest editorial: Genetic and epigenetic alterations in hematopoietic malignanciesToshio Kitamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 9, 2009
[Molecular bases of leukemia, MPD and MDS]Toshio Kitamura
International Journal of Hematology|July 8, 2019
Epigenetic abnormalities and therapies for hematological malignanciesToshio Kitamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Clonal hematopoiesis]Toshio Kitamura
Experimental Hematology|July 24, 2002
Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformationTetsuya Nosaka, Toshio Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Cytogenetic abnormalities and gene mutations in myeloid leukemia]Naoko Kato, Toshio Kitamura
Experimental Hematology|July 10, 2012
HDACI-induced thrombocytopenia is caused by its unexpected targetToshio Kitamura, Daichi Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 4, 2007
[Molecular mechanisms of carcinogenesis: an outline]Toshio Kitamura, Naoke Watanabe
Pageof 24